BlackRock Portfolio holdings
AUM
$5.23T
1-Year Est. Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
1 Year Est. Return
+24.48%
AUM
$4.74T
AUM Growth
-$191B
(-3.9%)
Holding
5,538
Top Buys
| 1 | +$3.73B | |
| 2 | +$2.82B | |
| 3 | +$2.65B | |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.55B |
| 5 |
Visa
V
|
+$2.45B |
Top Sells
| 1 | +$1.45B | |
| 2 | +$914M | |
| 3 | +$816M | |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$689M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$622M |
Sector Composition
| 1 | Technology | 28.01% |
| 2 | Financials | 13.82% |
| 3 | Healthcare | 11.49% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
ADC Therapeutics
ADCT
$479M
| $6.93M | ﹤0.01% |
4,913,628
-98,229
|
|
||
3352
GoPro
GPRO
$346M
| $6.91M | ﹤0.01% |
10,428,560
-537,457
|
|
||
3353
FuelCell Energy
FCEL
$346M
| $6.88M | ﹤0.01% |
1,499,022
+110,079
|
|
||
3354
Similarweb
SMWB
$753M
| $6.87M | ﹤0.01% |
831,068
+46,125
|
|
||
3355
iShares MSCI China A ETF
CNYA
$270M
| $6.85M | ﹤0.01% |
244,269
+7,699
|
|
||
3356
Lyell Immunopharma
LYEL
$334M
| $6.84M | ﹤0.01% |
636,079
-27,214
|
|
||
3357
Bel Fuse Inc Class A
BELFA
$1.51B
| $6.81M | ﹤0.01% |
94,538
-1,557
|
|
||
|
SEG
3358
Seaport Entertainment Group
SEG
$311M
| $6.79M | ﹤0.01% |
316,100
-10,196
|
|
||
3359
BRC Inc
BRCC
$159M
| $6.74M | ﹤0.01% |
3,224,126
-39,190
|
|
||
3360
TScan Therapeutics
TCRX
$127M
| $6.73M | ﹤0.01% |
4,878,833
-82,867
|
|
||
3361
Zentalis Pharmaceuticals
ZNTL
$115M
| $6.72M | ﹤0.01% |
4,229,497
-8,592
|
|
||
3362
Larimar Therapeutics
LRMR
$363M
| $6.72M | ﹤0.01% |
3,123,988
-141,917
|
|
||
3363
Contango ORE
CTGO
$385M
| $6.7M | ﹤0.01% |
656,622
-5,959
|
|
||
3364
eGain
EGAN
$386M
| $6.7M | ﹤0.01% |
1,380,908
-29,112
|
|
||
3365
Immunocore
IMCR
$1.73B
| $6.69M | ﹤0.01% |
225,545
-47,235
|
|
||
3366
Stereotaxis
STXS
$287M
| $6.67M | ﹤0.01% |
3,791,464
-106,421
|
|
||
3367
Materials Select Sector SPDR Fund
XLB
$5.48B
| $6.64M | ﹤0.01% |
77,228
+15,899
|
|
||
3368
Gencor Industries
GENC
$206M
| $6.63M | ﹤0.01% |
545,327
-10,003
|
|
||
3369
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$404M
| $6.62M | ﹤0.01% |
176,692
-1,141
|
|
||
3370
Clarus
CLAR
$127M
| $6.6M | ﹤0.01% |
1,761,216
-19,972
|
|
||
3371
Torrid Holdings
CURV
$145M
| $6.57M | ﹤0.01% |
1,199,134
+80,056
|
|
||
3372
Sanara MedTech
SMTI
$266M
| $6.52M | ﹤0.01% |
211,066
-3,933
|
|
||
3373
Atossa Therapeutics
ATOS
$136M
| $6.48M | ﹤0.01% |
9,625,365
-134,184
|
|
||
3374
Stevanato
STVN
$6.53B
| $6.46M | ﹤0.01% |
316,578
-171,633
|
|
||
3375
Pebblebrook Hotel Trust 6.375% Series E Preferred Shares
PEB.PRE
$84.8M
| $6.45M | ﹤0.01% |
+376,226
|
|